PHILADELPHIA -– Researchers at the University of Pennsylvania have developed a new electronic method for detecting microRNA isolated from living cells. MicroRNAs are a class of small biomolecules that control gene expression into proteins, the “workers” of the cell. MicroRNAs act by binding to specific messenger RNAs that code for proteins, and, by doing so, inhibit protein synthesis.
PHILADELPHIA – University of Pennsylvania President Amy Gutmann and Provost Vincent Price announced today that Michael Fitts has agreed to extend his term as dean of the Penn Law School until June 30, 2015.
Fitts became dean in 2000 and had been scheduled to step down on June 30, 2012.
The extension follows consultations with the entire Law School faculty, deans, senior officers of the University, the chairs of the Faculty Senate, Board of Trustees Chair David L. Cohen and Law Board of Overseers Chair Paul Haaga, all of whom praised Fitts’s accomplishments.
When most genes are transcribed, the nascent RNAs they produce are not quite ready to be translated into proteins - they have to be processed first. One of those processes is called splicing, a mechanism by which non-coding gene sequences are removed and the remaining protein-coding sequences are joined together to form a final, mature messenger RNA (mRNA), which contains the recipe for making a protein.
Penn’s Center for High Impact Philanthropy acknowledges a Philadelphia-based not-for-profit.
Marybeth Gasman of the Graduate School of Education comments on the impact the recession had on historically black colleges and universities.
Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer’s disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer’s disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.
The Penn Heart Rescue Program is cited for its expansion among community hospitals.